Barton P. Bandy's Net Worth
$1.13 Million
Who is Barton P. Bandy?
Barton P. Bandy has an estimated net worth of $1.13 Million. This is based on reported shares across multiple companies, which include ReShape Lifesciences Inc., and ReShape Lifesciences Inc..
SEC CIK
Barton P. Bandy's CIK is 0001773309
Past Insider Trading and Trends
2021 was Barton P. Bandy's most active year for acquiring shares with 2 total transactions. Barton P. Bandy's most active month to acquire stocks was the month of June. 2022 was Barton P. Bandy's most active year for disposing of shares, totalling 9 transactions. Barton P. Bandy's most active month to dispose stocks was the month of December. 2021 saw Barton P. Bandy paying a total of $0.00 for 1,186,006 shares, this is the most they've acquired in one year. In 2021 Barton P. Bandy cashed out on 333,991 shares for a total of $946,792.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ReShape Lifesciences Inc. (RSLS) Snapshot price: $0.1471
President and CEOBarton P. Bandy owns 773,098 units of Common Stock, $0.001 par value per share which is worth $113,722.72. In the year 2021 Barton P. Bandy filed a total of 13 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.49% | -11.67K |
$0.47 | -$5,486.78 | 773.1K |
Aug 5
| |||
Form 4
| -1.44% | -11.44K |
$0.55 | -$6,293.10 | 784.77K |
Jul 1
| |||
Form 4
| -1.40% | -11.31K |
$0.95 | -$10,770.54 | 796.21K |
Jun 1
| |||
Form 4
| -1.39% | -11.42K |
$0.77 | -$8,791.09 | 807.52K |
May 5
| |||
Form 4
| -1.33% | -11.06K |
$1.13 | -$12,501.19 | 818.94K |
Apr 1
| |||
Form 4
| -0.78% | -6.54K |
$1.06 | -$6,930.28 | 830K |
Feb 28
| |||
Form 4
| -0.99% | -8.32K |
$1.22 | -$10,155.28 | 836.54K |
Jan 31
| |||
Form 4
| -0.84% | -7.15K |
$1.79 | -$12,798.50 | 844.87K |
Jan 4
| |||
Form 4
| -1.55% | -13.43K |
$1.83 | -$24,571.41 | 852.01K |
Dec 2
| |||
Form 4
| -1.54% | -13.51K |
$2.69 | -$36,328.45 | 865.44K |
Nov 2
| |||
Form 4
| -1.41% | -12.56K |
$2.77 | -$34,805.05 | 878.95K |
Oct 1
| |||
Form 4
|
∞
| 891.51K |
$2.89 | -$851,087.66 | 891.51K |
Jul 22 - Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ReShape Lifesciences Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||